Alzheimer's Research & Therapy

Table 3 Results of multivariate regression analysis exploring the odds of having pathological values of p-tau/Aβ₄₂ in A + T − patients

From: Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study

	p-tau/Aβ₄₂ cut-off ≥ 0.086		p-tau/Aβ₄₂ cut-off ≥ 0.122
	Odds ratio (CI)	p	Odds ratio (CI)	p
amyR	23.27 (6.47–83.60)	< 0.001	8.82 (3.28–23.68)	< 0.001
Diabetes	0.38 (0.11–1.32)	0.13	0.51 (0.19–1.40)	0.19
Hypertension	0.99 (0.26–3.72)	0.99	1.25 (0.39–4.03)	0.71
Dyslipidemia	2.79 (0.71–10.95)	0.14	1.09 (0.34–3.47)	0.88
APOE4	5.93 (1.61–21.79)	0.007	1.27 (0.45–3.58)	0.65
Age	1.07 (0.99–1.14)	0.06	1.02 (0.96–1.07)	0.48
Sex	1.31 (0.43–4.03)	0.63	1.82 (0.68–4.91)	0.23

Bold values represent p-value < 0.05
amyR Aβ₄₂/Aβ₄₀, CI 95% confidence interval, p p-value

Back to article page

ISSN: 1758-9193

Contact us

General enquiries: journalsubmissions@springernature.com